IDRx’s $122 Million Series A Financing

Laura Testa
Tagged:

Ropes & Gray advised IDRx on the deal.Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to secure…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now